CME Group Accrued liabilities decreased by 78.2% to $20.90M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 136.6%, from -$57.10M to $20.90M. Over 3 years (FY 2021 to FY 2025), Accrued liabilities shows an upward trend with a 9.3% CAGR.
An increase acts as a source of cash, suggesting deferred payments, while a decrease acts as a use of cash, indicating the settlement of accrued obligations.
This represents the net change in short-term obligations that have been incurred but not yet paid, excluding standard ac...
Standard working capital metric found in the operating section of the cash flow statement for all public companies.
operating_increase_decrease_in_other_accrued_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $56.80M | $0.00 | $41.90M | $6.30M | $87.70M | -$106.70M | $84.00M | $79.20M | $586.20M | -$605.30M | -$113.10M | $0.00 | -$14.50M | -$57.10M | $125.00M | -$77.20M | $95.90M | $20.90M |
| QoQ Change | — | -100.0% | — | -85.0% | >999% | -221.7% | +178.7% | -5.7% | +640.2% | -203.3% | +81.3% | +100.0% | — | -293.8% | +318.9% | -161.8% | +224.2% | -78.2% |
| YoY Change | — | — | — | — | +109.3% | <-999% | — | — | +568.4% | -467.3% | -234.6% | -100.0% | -102.5% | +90.6% | +210.5% | — | +761.4% | +136.6% |